A Seattle-based protein design company, Arzeda raised $33M in a Series B funding round led by Conti Ventures, alongside contributions from Lewis & Clark Agrifood, Bunge Ventures, Circulate Capital, OS Fund, Casdin Capital, UMI and Bioeconomy Capital.
The new funding will help advance the company’s technology and enhance their existing commercialization portfolio. Arzeda has also posted seven new roles in engineering, testing, and research.
“Through key partnerships with leading companies such as Unilever and BP, we have achieved significant milestones in developing our portfolio of products,” said Alexandre Zanghellini, CEO of Arzeda. “With this funding, we will move our existing portfolio towards commercialization and increase our technology platform’s ability to further drive our mission of designing and manufacturing new proteins.”